NewYork-Presbyterian Hospital

screenshot of EndeavorRX gameplay
Akili to study EndeavorRx as a COVID-19 brain fog treatment
By Mallory Hackett | 11:41 am | April 09, 2021
The digital therapeutic is designed to treat children ages 8 to 12 with ADHD, but the two studies announced this week will focus on an adult population.   
Clinicians finding value in communicating with empathy
By HIMSS TV | 03:58 pm | May 16, 2019
Clinicians who attend communication and empathy workshops feel better about the care they deliver and how they communicate with patients, finds Steven Kaplan, MD, associate chief medical officer at NewYork-Presbyterian Hospital.